Nippon Express hub in Narita secures pharma certification
This is the second pharma-related certification awarded to the Nippon Express Narita hub, after it secured the GDP cert in March last year.
March 26, 2021
By PLA Editor
Air & Cargo Services air cargo Air Cargo Asia air cargo freight Air Forwarding air freight Air Freight Asia air freight forwarders Air Freight Logistics air freighter air freighting Air Logistics Asia Air Shipping Asia airlines cargo airways cargo asia cargo news cargo aviation CEIV Pharma IATA Nippon Express pharma shipments temperature controlled logistics temperature-sensitive cargo
Nippon Express has obtained its CEIV Pharma certification from IATA for its Narita temperature-controlled hub (NTCH), including transport operations between the facility and Narita Airport (NRT), effective 15 March.
Nippon said it began seeking certification in March 2019 with the airport community at NRT and with Narita International Airport Corporation’s assistance has now obtained certification as a forwarder in the community. This is the second pharmaceutical-related quality certification awarded to NTCH, after it secured the GDP certification in March last year.
The forwarder said it completed construction of four GDP-compliant pharma warehouses (East Japan, West Japan, Kyushu and Toyama) in Japan as part of its business plan to ‘prioritise the industry. It is also seeking GDP certification overseas apart from enhancing its business infrastructure.
“NTCH is an important node connecting Japan with the rest of the world, and this certification incorporating GDP standards from countries around the world will enable it to provide more secure and better-quality pharmaceutical transport services end-to-end,” Nippon Express said in a statement.